You are here

Home

Pályiné dr Krekk Zsuzsanna

Pályiné dr Krekk Zsuzsanna

Pályiné dr Krekk Zsuzsanna
DE
adjunktus
DE > ETK
DE > ETK
DE > ETK
DE > EK
Integrated Units
Scientific Unit
Gerontology Science Coordination Center
Name: Pályiné dr Krekk Zsuzsanna
Affiliation:
  • Debreceni Egyetem. Egészségtudományi Kar / University of Debrecen. Faculty of Health Sciences
  • Debreceni Egyetem. Egészségtudományi Kar. Egészségtudományi Intézet / University of Debrecen. Faculty of Health Sciences. Institute of Health Studies
  • Debreceni Egyetem. Egészségtudományi Kar. Egészségtudományi Intézet. Integratív Egészségtudományi Tanszék / University of Debrecen. Faculty of Health Sciences. Institute of Health Studies.
Other profiles: MTMT
Degree
  • PhD, DE (2008)

Publication list

printer-friendly version
Export to MTMT compatible RIS file
Upload publications
Request certified publication list
Uploaded publications:
7
Publications in DEA:
7
OA:
3
Date range:
2007-2021
2021
  1. Pályiné Krekk, Z.: Molekuláris gerontológia napjainkban.
    Magy. gerontol. 13 (40), 116-126, 2021.
2011
  1. Roszik, J., Sebestyén, Z., Govers, C., Guri, Y., Szöőr, Á., Pályiné Krekk, Z., Vereb, G., Nagy, P., Szöllősi, J., Debets, R.: T-cell synapse formation depends on antigen recognition but not CD3 interaction: studies with TCR : zeta, a candidate transgene for TCR gene therapy.
    Eur. J. Immunol. 41 (5), 1288-1297, 2011.
    Journal metrics:
    Q1 Immunology
    D1 Immunology and Allergy
2008
  1. Pályiné Krekk, Z., Barok, M., Kovács, T., Saya, H., Nagano, O., Szöllősi, J., Nagy, P.: EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44.
    Cancer Lett. 263 (2), 231-242, 2008.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
2007
  1. Pályiné Krekk, Z., Barok, M., Isola, J., Tammi, M., Szöllősi, J., Nagy, P.: Hyaluronan-induced masking of ErbB2 and CD44-enhanced trastuzumab internalisation in trastuzumab resistant breast cancer.
    Eur. J. Cancer. 43 (16), 2423-2433, 2007.
    Journal metrics:
    Q1 Cancer Research
    Q1 Oncology
  2. Barok, M., Isola, J., Pályiné Krekk, Z., Nagy, P., Juhász, I., Vereb, G., Kauraniemi, P., Kapanen, A., Tanner, M., Vereb, G., Szöllősi, J.: Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance.
    Mol. Cancer Ther. 6 (7), 2065-2072, 2007.
    Journal metrics:
    Q1 Cancer Research
    D1 Oncology
updated: 2024-12-15, 01:56

SCImago quartiles of
scientific journal articles

Number of scientific articles: 6
Q1/D1 2 (33.3%)
Q1 5 (83.3%)
N/A 1 (16.7%)
-
OK

SCImago subject areas and categories

Medicine (5)
Oncology (3)
Histology (1)
Immunology and Allergy (1)
Pathology and Forensic Medicine (1)
Biochemistry, Genetics and Molecular Biology (4)
Cancer Research (3)
Cell Biology (1)
Immunology and Microbiology (1)
Immunology (1)

Genre chart

Year chart

Language chart